JOHN B HENNEMAN III Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN B HENNEMAN III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is a EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK).
Address: C/O NEWLINK GENETICS CORPORATION 2700 VIA FORTUNA, SUITE 100 AUSTIN 78746 TX
Companies in which JOHN B HENNEMAN III is an Insider
LUMOS PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B HENNEMAN III: EVP, Chief Financial Officer
Holdings: 47,789 shares
Current Value: $653,276
Latest Transaction: Jan 06 2015
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN B HENNEMAN III
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 43.65 | 6,500 | 283,725 | 6,500 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Grant | A | 0.00 | 2,000 | 0 | 47,789 | 45.8 K to 47.8 K (+4.37 %) |
| Nov 25 2014 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Buy | P | 34.35 | 5,000 | 171,750 | 45,789 | 40.8 K to 45.8 K (+12.26 %) |
| Oct 03 2014 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 22.95 | 209,250 | 4,802,288 | 209,250 | |
| Oct 03 2014 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Grant | A | 0.00 | 40,789 | 0 | 40,789 | 0 to 40.8 K |